References
- De Hert, M., Dockx, L., Bernagie, C., Peuskens, B., Sweers, K., Leucht, S., … Peuskens, J. (2011). Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: A retrospective descriptive study. BMC Gastroenterology, 8, 17. doi:https://doi.org/10.1186/1471-230X-11-17
- De Hert, M., Hudyana, H., Dockx, L., Bernagie, C., Sweers, K., Tack, J., … Peuskens, J. (2011). Second-generation antipsychotics and constipation: A review of the literature. European Psychiatry, 26(1), 34–44. doi:https://doi.org/10.1016/j.eurpsy.2010.03.003
- De Hert, M., van Winkel, R., Silic, A., Van Eyck, D., & Peuskens, J. (2010). Physical health management in psychiatric settings. European Psychiatry, 25(Suppl. 2), S22–S28. doi:https://doi.org/10.1016/S0924-9338(10)71702-8
- Duran, C., Azermai, M., & Vander Stichele, R. (2013). Systematic review of anticholinergic risk scales in older adults. European Journal of Clinical Pharmacology, 69, 1485–1496. doi:https://doi.org/10.1007/s00228-013-1499-3
- Every-Palmer, S., Newton-Howes, G., & Clarke, M. J. (2017). Pharmacological treatment for antipsychotic-related constipation. Cochrane Database of Systematic Reviews, 1, CD011128. doi:https://doi.org/10.1002/14651858.CD011128.pub2
- Koizumi, T., Uchida, H., Suzuki, T., Sakurai, H., Tsunoda, K., Nishimoto, M., … Mimura, M. (2013). Oversight of constipation in inpatients with schizophrenia: A cross-sectional study. General Hospital Psychiatry, 35, 649–652. doi:https://doi.org/10.1016/j.genhosppsych.2013.06.007
- Lee-Robichaud, H., Thomas, K., Morgan, J., & Nelson, R. L. (2010). Lactulose versus Polyethylene Glycol for Chronic Constipation. Cochrane Database of Systematic Reviews, (7), CD007570. doi:https://doi.org/10.1002/14651858.CD007570.pub2
- Lertxundi, U., Domingo-Echaburu, S., Hernandez, R., Peral, J., & Medrano, J. (2013). Expert-based drug lists to measure anticholinergic burden: Similar names, different results. Psychogeriatrics, 13, 17–24. doi:https://doi.org/10.1111/j.1479-8301.2012.00418.x
- Lertxundi, U., Domingo-Echaburu, S., Hernández, R., Peral-Aguirregoitia, J., & Medrano, J. (2015). Confusion regarding anticholinergic burden measurement. Journal of the American Geriatrics Society, 63, 1054. doi:https://doi.org/10.1111/jgs.13411
- Lertxundi, U., Domingo-Echaburu, S., Ruiz-Osante, B., Hernandez Palacios, R., Peral Aguirregoitia, J., & Medrano Albeniz, J. (2013). Comments on Duran et al.’s systematic review of anticholinergic risk scales (EJCP 2DOI 10.1007/s00228-013-1499-3). European Journal of Clinical Pharmacology, 69, 1729. doi:https://doi.org/10.1007/s00228-013-1535-3
- Palmer, S. E., McLean, R. M., Ellis, P. M., & Harrison-Woolrych, M. (2008). Life-threatening clozapine-induced gastrointestinal hypomotility: An analysis of 102 cases. Journal of Clinical Psychiatry, 69, 759–768. doi:https://doi.org/10.4088/JCP.v69n0509
- Saha, S., Chant, D., & McGrath, J. (2007). A Systematic Review of Mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry, 64, 1123–1131. doi:https://doi.org/10.1001/archpsyc.64.10.1123
- Serrano Falcón, B., Barceló López, M., Mateos Muñoz, B., Álvarez Sánchez, A., & Rey, E. (2016). Fecal impaction: A systematic review of its medical complications. BMC Geriatrics, 16, 4. doi:https://doi.org/10.1186/s12877-015-0162-5
- Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2011). No mental health without physical health. Lancet, 377, 611. doi: https://doi.org/10.1016/S0140-6736(11)60211-0
- WHO Collaborating Centre for Drug Statistics Methodology. (2016). ATC/DDD Index. Retrieved from http://www.whocc.no/atc_ddd_index/